Alnylam Pharmaceuticals, Inc. (ALNY): Eastern Capital Owns 3.8 Million Shares

Page 7 of 8 SEC Filing

CUSIP No. 02043Q107	13G/A	Page 7

Item 5.  Ownership of Five Percent or
Less of a Class.

If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following     ☒.

Instruction. Dissolution of a group requires
a response to this item.

Item 6.  Ownership of More than Five Percent
on Behalf of Another Person.

Not Applicable

Item 7.  Identification and Classification
of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not Applicable

Item 8.  Identification and Classification
of Members of the Group.

Not Applicable

Item 9.  Notice of Dissolution of Group.

Not Applicable

Item 10.  Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Follow Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)

Follow Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)

---

or

Subscribe with Google

We may use your email to send marketing emails about our services. Click here to read our privacy policy.